Cardiac Rhythm Management Market Size, Share, & COVID-19 Impact Analysis | Global | 2022-2028 | MedSuite | Includes: Pacemakers, Cardiac Ablation Catheters, and 6 more

  • Year: 2022
  • Scope: 10 Years
  • Region: Global
  • Pages: 755
  • Published Date: 11/24/2022
  • Type: MedSuite

Product Description

Overall, the global cardiac rhythm management, electrophysiology & cardiac ablation market was valued at nearly $17.5 billion in 2021. This is expected to increase over the forecast period at a CAGR of 4.9% to reach over $24 billion.

The full report suite on the global market for cardiac rhythm management, electrophysiology & cardiac ablation includes pacemakers, implantable cardioverter-defibrillators (ICDs), cardiac resynchronization therapy devices (CRTs), cardiac leads, implantable loop recorders (ILRs), electrophysiology (EP) lab systems, diagnostic electrophysiology (EP) catheters and cardiac ablation catheters.

MARKET REPORT DATA TYPES INCLUDED

  • Unit SalesAverage Selling PricesMarket Size & Growth Trends
  • Procedure Numbers
  • COVID-19 Impact Analysis
  • Market Drivers & Limiters
  • Market Forecasts Until 2028, and Historical Data to 2018
  • Recent Mergers & Acquisitions
  • Company Profiles and Product Portfolios
  • Leading Competitors

GLOBAL CARDIAC RHYTHM MANAGEMENT MARKET TRENDS

global cardiac rhythm management

New technologies are constantly emerging in cardiac rhythm management and ablation. The capabilities and battery lifespan of pacemakers and ICDs have increased in the last decade. Over the forecast period, wireless technology is expected to make it easier for doctors to maintain and adjust pacemaker and ICD function. In addition, new technologies are expected to keep selling prices high and lead to a higher number of devices sold.

GLOBAL CARDIAC RHYTHM MANAGEMENT MARKET SHARE INSIGHTS 

Out of 60+ cardiac rhythm management device companies analyzed, the global market share is dominated by three key players – Medtronic, Abbott, Boston Scientific.

global cardiac rhythm management

Medtronic has maintained a strong presence in the total market for cardiac rhythm management (CRM), electrophysiology (EP) and ablation through brand recognition, strong customer support and a large sales force.

MARKET SEGMENTATION SUMMARY

While this report suite contains all global cardiac rhythm management devices data, each of the markets is also available as a stand-alone report, a MedCore.

  • Pacemaker Market – Includes:
    • Single-Chamber Pacemaker, Dual-Chamber Pacemaker, and Leadless Pacemaker
  • Implantable Cardioverter Defibrillator Market – Includes:
    • Single-Chamber ICD, Dual-Chamber ICD, and S-ICDs
  • Cardiac Resynchronization Therapy Device Market – Includes:
    • CRT-P, CRT-D
  • Cardiac Lead Market – Includes:
    • Pacing Lead, Defibrillation Lead, and LV Lead
  • Implant Loop Recorder Market 
  • Electrophysiology Lab System Market – Includes:
    • 3D Mapping System, EP Recording System
  • Diagnostic Electrophysiology Catheter Market – Includes:
    • Conventional EP Catheter, Advanced EP Catheter, and ICE Catheter
  • Cardiac Ablation Catheter Market – Includes:
    • RF Ablation Catheter, Cryoablation Catheter

RESEARCH SCOPE SUMMARY

Report AttributeDetails
RegionsNorth America (Canada, United States)
Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela)
Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.)
Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan,   Poland, Romania, Russia, Turkey, Ukraine)
Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates)
Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand,   Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam)
Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
Base Year2021
Forecast2022-2028
Historical Data2018-2021
Quantitative CoverageMarket Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
Qualitative CoverageCOVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
Data SourcesPrimary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

 

FREE Sample Report

Table of Contents

TABLE of CONTENTS
List of Figures
List of Charts
executive summary
Global Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Overview
Competitive Analysis
Market Trends
Market Developments
Procedures Included
Markets Included
Regions Included
Version History
research methodology
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
impact of covid-19 on THE global Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market
2.1 Introduction
2.2 Regional Profiles
2.3 Analysis By Market Segment
2.3.1 Worst Case Scenario
2.3.2 Base Case Scenario
2.3.3 Best Case Scenario
Disease Overview
3.1 Introduction
3.2 Types of Arrhythmias
3.2.11 Atrial Fibrillation
3.2.12 Bradycardia
3.2.13 Conduction Disorders
3.2.13.1 Bundle Branch Block
3.2.13.2 Heart Block
3.2.13.3 Long QT Syndrome (LQTS)
3.2.14 Premature Contractions: PACs and PVCs
3.2.15 Tachycardia
3.2.16 Ventricular Fibrillation
3.2.17 Other Rhythm Disorders
3.2.17.1 Adams-Stokes Disease
3.2.17.2 Atrial Flutter
3.2.17.3 Sick Sinus syndrome
3.2.17.4 Sinus Arrhythmia
3.2.17.5 Wolff-Parkinson-White Syndrome (WPW)
3.2.18 Types of Arrhythmia in Children
3.3 Heart Failure
3.4 Cardiac Arrest
3.5 Patient Demographics
3.5.11 Atrial Fibrillation
3.5.12 Bradycardia
3.5.13 Conduction Disorders
3.5.14 Premature Contractions – PACs and PVCs
3.5.15 Tachycardia
3.5.16 Ventricular Fibrillation
3.5.17 Other Rhythm Disorders
3.5.18 COVID & Arrhythmias
3.5.19 Heart Failure and Cardiac Arrest
Product Assessment
4.1 Introduction
4.2 Product Portfolios
4.2.1 Pacemakers
4.2.2 Implantable Cardioverter Defibrillators (ICDs)
4.2.3 Cardiac Resynchronization Therapy (CRT) Devices
4.2.4 Cardiac Leads
4.2.5 Implantable Loop Recorders
4.2.6 Electrophysiology Lab Systems
4.2.6.1 Introduction
4.2.6.2 3D Mapping Systems
4.2.6.3 EP Recording Systems
4.2.6.4 Remote Steering Systems
4.2.6.5 RF Ablation Generator
4.2.6.6 ICE Systems
4.2.7 Diagnostic EP Catheters
4.2.7.1 Introduction
4.2.7.2 Diagnostic EP Catheters
4.2.7.3 ICE Catheters
4.2.8 Cardiac Ablation Catheters
4.2.8.1 Introduction
4.2.8.2 RF Ablation Catheters
4.2.8.3 Alternative Energy Catheters
4.2.8.4 High Intensity Focused Ultrasound
4.3 Regulatory Issues and Recalls
4.3.1 Abbott
4.3.1.1 Pacemakers
4.3.1.2 Implantable Cardioverter Defibrillators (ICDs)
4.3.1.3 Cardiac Resynchronization Therapy (CRT) Devices
4.3.1.4 Cardiac Leads
4.3.1.5 EP Lab Devices
4.3.1.6 Cardiac Ablation Catheter
4.3.2 Biosense Webster
4.3.2.1 EP Lab Devices
4.3.2.2 Diagnostic EP Catheters
4.3.2.3 Cardiac Ablation Catheters
4.3.3 Boston Scientific
4.3.3.1 Pacemakers
4.3.3.2 Implantable Cardioverter Defibrillators (ICDs)
4.3.3.3 Cardiac Resynchronization Therapy (CRT) Devices
4.3.3.4 Cardiac Leads
4.3.3.5 EP Lab Devices
4.3.3.6 RF Ablation Catheter
4.3.4 Medtronic
4.3.4.1 Pacemakers
4.3.4.2 Implantable Cardioverter Defibrillators (ICDs)
4.3.4.3 Cardiac Resynchronization Therapy (CRT) Devices
4.3.4.4 Cardiac Leads
4.3.4.5 EP Lab Devices
4.3.5 MicroPort
4.3.5.1 Implantable Cardioverter Defibrillators (ICDs)
4.3.5.2 Cardiac Resynchronization Therapy (CRT) Devices
4.4 Clinical Trials
4.4.1 Pacemakers
4.4.2 Implantable Cardioverter Defibrillators (ICDs)
4.4.3 Cardiac Resynchronization Therapy (CRT) Devices
4.4.4 Cardiac Leads
4.4.5 Lab Systems
4.4.5.1 3D Mapping Systems
4.4.5.2 EP Recording Systems
4.4.5.3 RF Ablation Generators
4.4.5.4 ICE Systems
4.4.6 Diagnostic EP Catheters
4.4.6.1 Diagnostic Catheter
4.4.7 Cardiac Ablation Catheter
4.4.7.1 RF Ablation Catheters
4.4.7.2 Cryoablation Catheters
4.4.7.4 Laser Ablation Catheters
Global Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Overview
5.1 Introduction
5.2 Market Overview & Trend Analysis
5.2.1 By Segment
5.2.2 By Region
5.3 Drivers and Limiters
5.3.1 Market Drivers
5.3.2 Market Limiters
5.4 Competitive Market Share Analysis
5.5 Mergers and Acquisitions
5.6 Company Profiles
5.6.1 Abbott
5.6.2 Biosense Webster
5.6.3 Biotronik
5.6.4 Boston Scientific
5.6.5 GE Healthcare
5.6.6 Medtronic
5.6.7 MicroPort
5.7 SWOT Analysis
5.7.1 Abbott
5.7.2 Biosense Webster
5.7.3 Biotronik
5.7.4 Boston Scientific
5.7.5 GE Healthcare
5.7.6 Medtronic
5.7.7 MicroPort
Pacemaker Market
6.1 Executive Summary
6.1.1 Global Pacemaker Market Overview
6.1.2 Competitive Analysis
6.1.3 Procedures Included
6.1.4 Markets Included
6.1.5 Regions Included
6.2 Introduction
6.2.1 Single and Dual-Chamber Devices
6.2.2 MRI-Compatible Pacemaker
6.2.3 Leadless Pacemaker
6.2.4 Initial Placement and Replacement of Pacemakers
6.3 Procedure Numbers
6.3.1 Total Pacemaker Placement Procedures
6.3.2 Initial Placement Pacemaker Procedures
6.3.3 Replacement Pacemaker Procedures
6.4 Market Overview
6.4.1 By Segment
6.4.2 By Region
6.5 Market Analysis and Forecast
6.5.1 Total Pacemaker Market
6.5.2 Single-Chamber Pacemaker Market
6.5.2.1 Initial Placement Single-Chamber Pacemaker Market
6.5.2.2 Replacement Single-Chamber Pacemaker Market
6.5.3 Dual-Chamber Pacemaker Market
6.5.3.1 Initial Placement Dual-Chamber Pacemaker Market
6.5.3.2 Replacement Dual-Chamber Pacemaker Market
6.5.4 Leadless Pacemaker Market
6.5.4.1 Initial Placement Leadless Pacemaker Market
6.5.4.2 Replacement Leadless Pacemaker Market
6.6 Drivers and Limiters
6.6.1 Market Drivers
6.6.2 Market Limiters
6.7 Competitive Market Share Analysis
Implantable Cardioverter defibrillator Market
7.1 Executive Summary
7.1.1 Global Implantable Cardioverter Defibrillator Market Overview
7.1.2 Competitive Analysis
7.1.3 Procedures Included
7.1.4 Markets Included
7.1.5 Regions Included
7.2 Introduction
7.3 Procedure Numbers
7.3.1 Total ICD Placement Procedures
7.3.2 Initial Placement ICD Procedures
7.3.3 Replacement ICD Procedures
7.4 Market Overview
7.4.1 By Segment
7.4.2 By Region
7.5 Market Analysis and Forecast
7.5.1 Total ICD Market
7.5.2 Single-Chamber ICD Market
7.5.2.1 Initial Placement Single-Chamber ICD Market
7.5.2.2 Replacement Single-Chamber ICD Market
7.5.3 Dual-Chamber ICD Market
7.5.3.1 Initial Placement Dual-Chamber ICD Market
7.5.3.2 Replacement Dual-Chamber ICD Market
7.5.4 S-ICD Market
7.5.4.1 Initial Placement S-ICD Market
7.5.4.2 Replacement S-ICD Market
7.6 Drivers and Limiters
7.6.1 Market Drivers
7.6.2 Market Limiters
7.7 Competitive Market Share Analysis
Cardiac Resynchronization Therapy Device Market
8.1 Executive Summary
8.1.1 Global Cardiac Resynchronization Therapy Device Market Overview
8.1.2 Competitive Analysis
8.1.3 Procedures Included
8.1.4 Markets Included
8.1.5 Regions Included
8.2 Introduction
8.2.1 Cardiac Resynchronization Therapy-Pacemakers (CRT-Ps)
8.2.2 Cardiac Resynchronization Therapy-Defibrillators (CRT-Ds)
8.3 Procedure Numbers
8.3.1 Total CRT Placement Procedures
8.3.2 Initial Placement CRT Procedures
8.3.3 Replacement CRT Procedures
8.4 Market Overview
8.4.1 By Segment
8.4.2 By Region
8.5 Market Analysis and Forecast
8.5.1 Total CRT Device Market
8.5.2 CRT-P Market
8.5.2.1 Initial Placement CRT-P Market
8.5.2.2 Replacement CRT-P Market
8.5.3 CRT-D Market
8.5.3.1 Initial Placement CRT-D Market
8.5.3.2 Replacement CRT-D Market
8.6 Drivers and Limiters
8.6.1 Market Drivers
8.6.2 Market Limiters
8.7 Competitive Market Share Analysis
Cardiac Lead Market
9.1 Executive Summary
9.1.1 Global Cardiac Lead Market Overview
9.1.2 Competitive Analysis
9.1.3 Markets Included
9.1.4 Regions Included
9.2 Introduction
9.2.1 Replacement of Leads
9.3 Market Overview
9.3.1 By Segment
9.3.2 By Region
9.4 Market Analysis and Forecast
9.4.1 Total Cardiac Lead Market
9.4.2 Pacing Lead Market
9.4.3 Defibrillation Lead Market
9.4.4 LV Lead Market
9.5 Drivers and Limiters
9.5.1 Market Drivers
9.5.2 Market Limiters
9.6 Competitive Market Share Analysis
Implantable Loop Recorder Market
10.1 Executive Summary
10.1.1 Global Implantable Loop Recorder Market Overview
10.1.2 Competitive Analysis
10.1.3 Regions Included
10.2 Introduction
10.3 Procedure Numbers
10.4 Market Analysis and Forecast
10.5 Drivers and Limiters
10.5.1 Market Drivers
10.5.2 Market Limiters
10.6 Competitive Market Share Analysis
Electrophysiology Lab System Market
11.1 Executive Summary
11.1.1 Global Electrophysiology Lab System Market Overview
11.1.2 Competitive Analysis
11.1.3 Markets Included
11.1.4 Regions Included
11.2 Introduction
11.2.1 3D Mapping Systems
11.2.2 EP Recording Systems
11.3 Market Overview
11.3.1 By Segment
11.3.2 By Region
11.4 Market Analysis and Forecast
11.4.1 Total Electrophysiology Lab System Market
11.4.2 3D Mapping System Market
11.4.3 EP Recording System Market
11.5 Drivers and Limiters
11.5.1 Market Drivers
11.5.2 Market Limiters
11.6 Competitive Market Share Analysis
Diagnostic Electrophysiology Catheter Market
12.1 Executive Summary
12.1.1 Global Diagnostic Electrophysiology Catheter Market Overview
12.1.2 Competitive Analysis
12.1.3 Markets Included
12.1.4 Regions Included
12.2 Introduction
12.2.1 Diagnostic Electrophysiology Catheters
12.2.2 Intracardiac Echocardiography
12.3 Procedure Numbers
12.4 Market Overview
12.4.1 By Segment
12.4.2 By Region
12.5 Market Analysis and Forecast
12.5.1 Total Diagnostic Electrophysiology Catheter Market
12.5.2 Conventional Electrophysiology Catheter Market
12.5.3 Advanced Electrophysiology Catheter Market
12.5.4 ICE Catheter Market
12.6 Drivers and Limiters
12.6.1 Market Drivers
12.6.2 Market Limiters
12.7 Competitive Market Share Analysis
Cardiac Ablation Catheter Market
13.1 Executive Summary
13.1.1 Global Cardiac Ablation Catheter Market Overview
13.1.2 Competitive Analysis
13.1.3 Procedures Included
13.1.4 Markets Included
13.1.5 Regions Included
13.2 Introduction
13.3 Procedure Numbers
13.3.1 Total Cardiac Ablation Procedures
13.3.2 RF Ablation Procedures
13.3.3 Cryoablation Procedures
13.4 Market Overview
13.4.1 By Segment
13.4.2 By Region
13.5 Market Analysis and Forecast
13.5.1 Total Cardiac Ablation Catheter Market
13.5.2 RF Ablation Catheter Market
13.5.3 Cryoablation Catheter Market
13.6 Drivers and Limiters
13.6.1 Market Drivers
13.6.2 Market Limiters
13.7 Competitive Market Share Analysis
Abbreviations

Companies Included:

·         Abbott·         Lepu Medical
·         Angel Medical Systems·         Medico
·         AngioDynamics·         Medtronic
·         AtriCure·         MicroPort
·         Biosense Webster·         Pacetronix
·         Biotronik·         Philips
·         Boston Scientific·         Schwarzer Cardiotek
·         CathVision·         Siemens
·         GE Healthcare·         Stereotaxis
·         Imricor Medical Systems·         Vectorious
·         JJET

List of Charts

Chart 1‑1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Global, 2021 – 2028
Chart 1‑2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Procedures, Global, 2021
Chart 2‑1: Multi-Scenario Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Forecast, Global, 2018 – 2028 (US$M)
Chart 5‑1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Global, 2018 – 2028
Chart 5‑2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Region, Global, 2018 – 2028
Chart 5‑3: Leading Competitors, Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, Global, 2021
Chart 6‑1: Pacemaker Market, Global, 2018 – 2028
Chart 6‑2: Pacemaker Placement Procedures, Global, 2021
Chart 6‑3: Pacemaker Placement Procedures by Segment, Global, 2018 – 2028
Chart 6‑4: Pacemaker Market by Segment, Global, 2018 – 2028
Chart 6‑5: Pacemaker Market by Region, Global, 2018 – 2028
Chart 6‑6: Leading Competitors, Pacemaker Market, Global, 2021
Chart 7‑1: ICD Market, Global, 2018 – 2028
Chart 7‑2: ICD Placement Procedures, Global, 2021
Chart 7‑3: ICD Placement Procedures by Segment, Global, 2018 – 2028
Chart 7‑4: ICD Market by Segment, Global, 2018 – 2028
Chart 7‑5: ICD Market by Region, Global, 2018 – 2028
Chart 7‑6: Leading Competitors, ICD Market, Global, 2021
Chart 8‑1: CRT Device Market, Global, 2018 – 2028
Chart 8‑2: CRT Device Placement Procedures, Global, 2021
Chart 8‑3: CRT Placement Procedures by Segment, Global, 2018 – 2028
Chart 8‑4: CRT Device Market by Segment, Global, 2018 – 2028
Chart 8‑5: CRT Device Market by Region, Global, 2018 – 2028
Chart 8‑6: Leading Competitors, CRT Device Market, Global, 2021
Chart 9‑1: Cardiac Lead Market, Global, 2018 – 2028
Chart 9‑2: Cardiac Lead Units Sold, Global, 2021
Chart 9‑3: Cardiac Lead Market by Segment, Global, 2018 – 2028
Chart 9‑4: Cardiac Lead Market by Region, Global, 2018 – 2028
Chart 9‑5: Leading Competitors, Cardiac Lead Market, Global, 2021
Chart 10‑1: Implantable Loop Recorder Market, Global, 2018 – 2028
Chart 10‑2: Implantable Loop Recorder Placement Procedures, Global, 2021
Chart 10‑3: Implantable Loop Recorder Placement Procedures by Region, Global, 2018 – 2028
Chart 10‑4: Implantable Loop Recorder Device Market, Global, 2018 – 2028
Chart 10‑5: Leading Competitors, Implantable Loop Recorder Market, Global, 2021
Chart 11‑1: Electrophysiology Lab System Market, Global, 2018 – 2028
Chart 11‑2: Electrophysiology Lab System Procedures, Global, 2021
Chart 11‑3: Electrophysiology Lab System Market by Segment, Global, 2018 – 2028
Chart 11‑4: Electrophysiology Lab System Market by Region, Global, 2018 – 2028
Chart 11‑5: Leading Competitors, Electrophysiology Lab System Market, Global, 2021
Chart 12‑1: Diagnostic Electrophysiology Catheter Market, Global, 2018 – 2028
Chart 12‑2: Diagnostic Electrophysiology Catheter Procedures, Global, 2021
Chart 12‑3: Diagnostic Electrophysiology Procedures, Global, 2018 – 2028
Chart 12‑4: Diagnostic Electrophysiology Catheter Market by Segment, Global, 2018 – 2028
Chart 12‑5: Diagnostic Electrophysiology Catheter Market by Region, Global, 2018 – 2028
Chart 12‑6: Leading Competitors, Diagnostic Electrophysiology Catheter Market, Global, 2021
Chart 13‑1: Cardiac Ablation Catheter Market, Global, 2018 – 2028
Chart 13‑2: Cardiac Ablation Catheter Procedures, Global, 2021
Chart 13‑3: Cardiac Ablation Procedures by Segment, Global, 2018 – 2028
Chart 13‑4: Cardiac Ablation Catheter Market by Segment, Global, 2018 – 2028
Chart 13‑5: Cardiac Ablation Catheter Market by Region, Global, 2018 – 2028
Chart 13‑6: Leading Competitors, Cardiac Ablation Catheter Market, Global, 2021

List of Figures

Figure 1‑1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Share Ranking by Segment, Global, 2021 (1 of 2)
Figure 1‑2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Share Ranking by Segment, Global, 2021 (2 of 2)
Figure 1‑3: Companies Researched in this Report
Figure 1‑4: Factors Impacting the Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Global (1 of 2)
Figure 1‑5: Factors Impacting the Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Global (2 of 2)
Figure 1‑6: Recent Events in the Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, Global, 2018 – 2022 (1 of 2)
Figure 1‑7: Recent Events in the Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, Global, 2018 – 2022 (2 of 2)
Figure 1‑8: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Procedures Covered
Figure 1‑9: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Markets Covered (1 of 2)
Figure 1‑10: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Markets Covered (2 of 2)
Figure 1‑11: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Regions Covered, Global (1 of 2)
Figure 1‑12: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Regions Covered, Global (2 of 2)
Figure 1‑13: Version History
Figure 2‑1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Worst Case Scenario, Global, 2018 – 2028 (US$M)
Figure 2‑2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Base Case Scenario, Global, 2018 – 2028 (US$M)
Figure 2‑3: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Best Case Scenario, Global, 2018 – 2028 (US$M)
Figure 4‑1: Pacemaker Market Products by Company
Figure 4‑2: ICD Market Products by Company
Figure 4‑3: CRT Device Market Products by Company (1 of 2)
Figure 4‑4: CRT Device Market Products by Company (2 of 2)
Figure 4‑5: Cardiac Lead Market Products by Company
Figure 4‑6: Implantable Loop Recorder Market Products by Company
Figure 4‑7: EP Lab System Market Products by Company
Figure 4‑8: Diagnostic EP Catheter Market Products by Company
Figure 4‑9: Cardiac Ablation Catheter Products by Company (1 of 2)
Figure 4‑10: Cardiac Ablation Catheter Products by Company (2 of 2)
Figure 4‑11: Class 1 Device Recall Assurity pacemakers
Figure 4‑12: Class 1 Device Recall St. Jude Endurity Pacemakers
Figure 4‑13: Class 1 Device Recall Fortify, Unify, Assura, including Quadra
Figure 4‑14: Class 2 Device Recall Ellipse
Figure 4‑15: Class 2 Device Recall Quadra Assura
Figure 4‑16: Class 2 Device Recall Unify Assura
Figure 4‑17: Class 2 Device Recall Unify Quadra
Figure 4‑18: Class 2 Device Recall Promote Quadra
Figure 4‑19: Class 2 Device Recall Allure Quadra
Figure 4‑20: Class 2 Device Recall Allure Quadra
Figure 4‑21: Class 2 Device Recall Anthem, Allure
Figure 4‑22: Class 2 Device Recall Nuance
Figure 4‑23: Class 1 Device Recall Optisure HV lead
Figure 4‑24: Class 2 Device Recall FIRMap
Figure 4‑25: Class 2 Device Recall WorkMate Claris, v.1.2 Upgrade Kits
Figure 4‑26: Class 3 Device Recall FIRMap 60mm Catheter
Figure 4‑27: Class 2 Device Recall Abbott
Figure 4‑28: Class 2 Device Recall TactiSys Quartz Pack, PN004 400
Figure 4‑29: Class 2 Device Recall CARTO 3 System
Figure 4‑30: Class 2 Device Recall SMARTABLATE RF Generator System
Figure 4‑31: Class 2 Device Recall ACUSON AcuNav Volume ICE Catheter
Figure 4‑32: Class 2 Device Recall PENTARAY NAV eco HighDensity Mapping Catheter
Figure 4‑33: Class 2 Device Recall PENTARAY NAV HighDensity Mapping Catheter
Figure 4‑34: Class 2 Device Recall SOUNDSTAR eco Catheter
Figure 4‑35: Class 2 Device Recall WEBSTER Fixed Curve Catheter with Auto ID Technology
Figure 4‑36: Class 2 Device Recall THERMOCOOL SMARTTOUCH
Figure 4‑37: Class 1 Device Recall ADVANTIO DR EL
Figure 4‑38: Class 1 Device Recall INGENIO DR EL
Figure 4‑39: Class 1 Device Recall VITALIO DR EL
Figure 4‑40: Class 2 Device Recall Accolade
Figure 4‑41: Class 2 Device Recall Essentio
Figure 4‑42: Class 2 Device Recall EMBLEM
Figure 4‑43: Class 1 Device Recall EMBLEM
Figure 4‑44: Class 2 Device Recall ESSENTIO Pacemaker
Figure 4‑45: Class 2 Device Recall PROPONENT Pacemaker
Figure 4‑46: Class 2 Device Recall ACCOLADE Pacemaker
Figure 4‑47: Class 2 Device Recall ACCOLADE MRI Pacemaker
Figure 4‑48: Class 2 Device Recall ESSENTIO MRI Pacemaker
Figure 4‑49: Class 2 Device Recall ESSENTIO Pacemaker
Figure 4‑50: Class 2 Device Recall PROPONENT Pacemaker
Figure 4‑51: Class 2 Device Recall PROPONENT MRI Pacemaker
Figure 4‑52: Class 2 Device Recall ALTRUA 2 EL DR Pacemaker
Figure 4‑53: Class 2 Device Recall ALTRUA 2 SR Pacemaker
Figure 4‑54: Class 2 Device Recall ALTRUA 2 DR Pacemaker
Figure 4‑55: Class 2 Device Recall Accolade MRI and Essentio MRI pacemakers
Figure 4‑56: Class 2 Device Recall EMBLEM
Figure 4‑57: Class 2 Device Recall EMBLEM
Figure 4‑58: Class 1 Device Recall EMBLEM
Figure 4‑59: Class 2 Device Recall DYNAGEN EL ICD DR
Figure 4‑60: Class 2 Device Recall Implantable Cardioverter Defibrillator (NonCRT)
Figure 4‑61: Class 2 Device Recall RESONATE EL ICD VR/DR
Figure 4‑62: Class 2 Device Recall EMBLEM SICD, Model A209
Figure 4‑63: Class 2 Device Recall SQRX 1010 Pulse Generator
Figure 4‑64: Class 2 Device Recall EMBLEM MRI SICD Model 219
Figure 4‑65: Class 2 Device Recall SQRX Model 1010 Subcutaneous Pulse Generator
Figure 4‑66: Class 1 Device Recall INTUA CRTP
Figure 4‑67: Class 1 Device Recall INVIVE CRTP
Figure 4‑68: Class 2 Device Recall VISIONIST CRTP
Figure 4‑69: Class 2 Device Recall VALITUDE CRTP
Figure 4‑70: Class 2 Device Recall VALITUDE X4 CRTP (Cardiac Resynchronization Therapy Pacemaker)
Figure 4‑71: Class 2 Device Recall VALITUDE X4 CRTP Pacemaker
Figure 4‑72: Class 2 Device Recall VALITUDE CRTP Pacemaker
Figure 4‑73: Class 2 Device Recall VISIONIST X4 CRTP Pacemaker
Figure 4‑74: Class 2 Device Recall VISIONIST CRTP Pacemaker
Figure 4‑75: Class 2 Device Recall RESONATE X4 CRTD
Figure 4‑76: Class 2 Device Recall MOMENTUM X4 CRTD
Figure 4‑77: Class 2 Device Recall VIGILANT X4 CRTD
Figure 4‑78: Class 2 Device Recall Boston Scientific, INGEVITY MRI Leads, Sterile EO, RxOnly
Figure 4‑79: Class 2 Device Recall iLab Polaris MultiModality Guidance System
Figure 4‑80: Class 2 Device Recall Maestro 4000 Cardiac Ablation System
Figure 4‑81: Class 2 Device Recall CLEARSIGN II Amplifier for LABSYSTEM PRO EP Recording System
Figure 4‑82: Class 3 Device Recall Cardiac Ablation Percutaneous Catheters
Figure 4‑83: Class 1 Device Recall Intella Tip MiFi Open Irrigated Ablation Catheter
Figure 4‑84: Class 2 Device Recall Astra XT DR Implantable pulse generator
Figure 4‑85: Class 2 Device Recall Azure
Figure 4‑86: Class 2 Device Recall Azure XT DR MRI
Figure 4‑87: Class 2 Device Recall Azure S DR MRI
Figure 4‑88: Class 2 Device Recall Azure XT SR MRI
Figure 4‑89: Class 2 Device Recall Azure S SR MRI
Figure 4‑90: Class 2 Device Recall Medtronic Micra MC1VR01
Figure 4‑91: Class 1 Device Recall SPHERA, Dual chamber pacemaker
Figure 4‑92: Class 1 Device Recall SENSIA, Dual chamber pacemaker
Figure 4‑93: Class 1 Device Recall VERSA, Dual chamber pacemaker
Figure 4‑94: Class 1 Device Recall ADAPTA, Dual chamber pacemaker
Figure 4‑95: Class 1 Device Recall ATTESTA L DR MRI SureScan, Dual chamber rate responsive pacemaker
Figure 4‑96: Class 2 Device Recall Medtronic Model 53401 Single Chamber External Pulse Generator
Figure 4‑97: Class 2 Device Recall Medtronic Model 5392 Dual Chamber Temporary External Pulse Generator
Figure 4‑98: Class 1 Device Recall Cobalt
Figure 4‑99: Class 1 Device Recall Crome
Figure 4‑100: Class 1 Device Recall Evera and Visia
Figure 4‑101: Class 2 Device Recall EnTrust Dual Chamber Implantable Cardioverter Defibrillator with Atrial and Ventricular Therapies
Figure 4‑102: Class 2 Device Recall EnTrust Single Chamber Implantable Cardioverter Defibrillator with Atrial and Ventricular Therapies
Figure 4‑103: Class 2 Device Recall Medtronic EnTrust Escudo
Figure 4‑104: Class 1 Device Recall Evera MRI XT DR ICD, Evera MRI XT VR ICD, Evera MRI S DR ICD
Figure 4‑105: Class 1 Device Recall Visia AF MRI VR SureScan ICD
Figure 4‑106: Class 1 Device Recall Visia AF VR ICD
Figure 4‑107: Class 1 Device Recall Evera S DR ICD, Evera S VR ICD, Evera XT DR ICD, Evera XT VR ICD
Figure 4‑108: Class 2 Device Recall Evera ICD
Figure 4‑109: Class 2 Device Recall Viva ICD
Figure 4‑110: Class 1 Device Recall Cobalt
Figure 4‑111: Class 1 Device Recall Crome
Figure 4‑112: Class 2 Device Recall Cobalt
Figure 4‑113: Class 2 Device Recall Precepta
Figure 4‑114: Class 2 Device Recall Percepta, Serena, and Solara CRTP MRI
Figure 4‑115: Class 1 Device Recall Viva, Claria, Amplia, Compia, and Brava
Figure 4‑116: Class 2 Device Recall Percepta CRTP MRI
Figure 4‑117: Class 2 Device Recall Solara CRTP MRI
Figure 4‑118: Class 2 Device Recall Serena CRTP MRI
Figure 4‑119: Class 2 Device Recall Percepta CRTP MRI SureScan
Figure 4‑120: Class 2 Device Recall Percepta Quad CRTP MRI SureScan
Figure 4‑121: Class 1 Device Recall Amplia MRI CRTD, Amplia MRI Quad CRTD
Figure 4‑122: Class 1 Device Recall Viva Quad S CRTD, Viva Quad XT CRTD, Viva S CRTD, Viva XT CRTD
Figure 4‑123: Class 1 Device Recall Compia MRI CRTD, Compia MRI Quad CRTD
Figure 4‑124: Class 2 Device Recall Amplia MRI Quad CRT0 SureScanClaria MRI Quad CRTD SureScanCompia MRI Quad CRTD SureScan
Figure 4‑125: Class 2 Device Recall InSync III
Figure 4‑126: Class 2 Device Recall Sprint Quattro
Figure 4‑127: Class 2 Device Recall Medtronic, Temporary Pacing Lead System
Figure 4‑128: Class 2 Device Recall Achieve Electrical Cable
Figure 4‑129: Class 2 Device Recall Medtronic CryoConsole
Figure 4‑130: Class 2 Device Recall Platinium Implantable Cardiac Defibrillator and Resynchronization Therapy Defibrillator
Figure 4‑131: Class 2 Device Recall Platinium DR 1510
Figure 4‑132: Class 2 Device Recall Platinium VR 1210
Figure 4‑133: Class 2 Device Recall Platinium DR DF4 1540
Figure 4‑134: Class 2 Device Recall Platinium VR DF4 1240
Figure 4‑135: Class 2 Device Recall PARADYM
Figure 4‑136: Class 2 Device Recall OVATIO
Figure 4‑137: Class 2 Device Recall INTENSIA
Figure 4‑138: Class 2 Device Recall Platinium Implantable Cardiac Defibrillator and Resynchronization Therapy Defibrillator
Figure 4‑139: Class 2 Device Recall Platinium CRTD 1741
Figure 4‑140: Class 2 Device Recall Platinium CRT DF1 1711
Figure 4‑141: Class 2 Device Recall PARADYM
Figure 4‑142: Class 2 Device Recall OVATIO
Figure 4‑143: Class 2 Device Recall INTENSIA
Figure 4‑144: The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System
Figure 4‑145: Aveir VR Coverage With Evidence Development Post-Approval Study (CED)
Figure 4‑146: A Retrospective Trial to Evaluate the Micra Pacemaker (Micra)
Figure 4‑147: Project My Heart Your Heart: Pacemaker Reuse (MHYH)
Figure 4‑148: Evaluation of Atrial Fibrillation Occurrence in Sick Sinus and Complete Atrioventricular Block Patients After Pacemaker Implantation (AF-pacemaker Study)
Figure 4‑149: Longitudinal Coverage With Evidence Development Study on Micra Leadless Pacemakers
Figure 4‑150: Heart Failure Indication and Sudden Cardiac Death Prevention Trial Japan
Figure 4‑151: BIO|MASTER.Edora Family Study
Figure 4‑152: China Micra Transcatheter Pacing Study
Figure 4‑153: Optimizing Pacemaker Therapy Using Multi-Point Pacing (the OPT-MPP Study)
Figure 4‑154: Electrical Cardioversion, Ablation or Pace and Ablate for Persistent Atrial Fibrillation - The CAPAPAF-65 Study
Figure 4‑155: Advanced Bradycardia Device Feature Utilization and Clinical Outcomes II
Figure 4‑156: Observation of ImageReady™ MR Conditional Pacing System in China
Figure 4‑157: Micra Transcatheter Pacing System Continued Access Study Protocol
Figure 4‑158: Extravascular ICD Pivotal Study (EV ICD)
Figure 4‑159: Defibrillation Testing During Implantable Cardioverter Defibrillator (ICD) Replacement (T-DEF)
Figure 4‑160: Master Study of the Acticor/Rivacor ICDs/CRT-Ds and the Plexa ProMRI S DX Lead
Figure 4‑161: A Post-market Clinical Evaluation of St. Jude Medical™ MR Conditional ICD System on Patients Undergoing Magnetic Resonance Imaging (ASIA MRI ICD)
Figure 4‑162: Effectiveness of the EMPOWER™ Modular Pacing System and EMBLEM™ Subcutaneous ICD to Communicate Antitachycardia Pacing (MODULAR ATP)
Figure 4‑163: Acute Feasibility Investigation of a New S-ICD Electrode (ASE)
Figure 4‑164: Understanding Outcomes With the EMBLEM™ S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED)
Figure 4‑165: A PRospective, rAndomizEd Comparison of subcuTaneOous and tRansvenous ImplANtable Cardioverter Defibrillator Therapy (PRAETORIAN)
Figure 4‑166: Comparison of CRT-D and CRT-DX Systems (CRT-NEXT)
Figure 4‑167: Increasing Detection of Sub-Clinical Atrial Fibrillation in Defibrillator Patients with the Use of a VDD-ICD Lead (Dx-AF)
Figure 4‑168: Multicenter Automatic Defibrillator Implantation Trial with Subcutaneous Implantable Cardioverter Defibrillator (MADIT S-ICD)
Figure 4‑169: Extravascular ICD Pilot Study
Figure 4‑170: Acute Feasibility Investigation of a New S-ICD Electrode
Figure 4‑171: Subcutaneous ICD Therapy Combined with VT Ablation for the Secondary Prevention of Sudden Cardiac Death
Figure 4‑172: BIO|MASTER.Ilivia Family/Plexa
Figure 4‑173: Metabolic Mapping and Cardiac Resynchronization
Figure 4‑174: CRT-P or CRT-D in Dilated Cardiomyopathy (CRT-REALITY)
Figure 4‑175: Safety and Performance Aspects of CRT-DX System in Patients with Sinus Rhythm (BIO|REDUCE)
Figure 4‑176: Prospective Randomized Trial Comparing TRIPLE Site ventricular Stimulation Versus Conventional Pacing in CRT candidates: TRIPLEAD Trial
Figure 4‑177: Re-evaluation of Optimal Re-synchronization Therapy in Patients with Chronic Heart Failure
Figure 4‑178: The His Optimised Pacing Evaluated for Heart Failure Trial (HOPE-HF)
Figure 4‑179: Cardiac Resynchronisation Therapy Versus Rate-responsive Pacing in Heart Failure With Preserved Ejection Fraction (PREFECTUS)
Figure 4‑180: Cardiac Resynchronization in the Elderly
Figure 4‑181: Standard Care Versus Triventricular Pacing in Heart Failure (STRIVE HF)
Figure 4‑182: Responders and Quadripolar LV Lead in CRT
Figure 4‑183: Does Electric Targeted LV Lead Positioning Improve Outcome in Patients With Heart Failure and Prolonged QRS
Figure 4‑184: SD01 Master Study (Safety and Efficacy Study)
Figure 4‑185: Assessment of the Axone Micro Quadripolar Lead for Enhanced Cardiac Resynchronization Therapy (ASTRAL-4LV)
Figure 4‑186: Safety and Performance of INVICTA Ventricular DF4 LEADS With Active Fixation-(APOLLO)
Figure 4‑187: Safety and Electrical Performance Evaluation of INVICTA Leads Models Equipped With DF4 Connector (FRIENDS)
Figure 4‑188: Safety and Electrical Performances Evaluation of Navigo Leads Equipped with IS4 Connector (NAVIGATOR)
Figure 4‑189: Avoid Transvenous Leads in Appropriate Subjects
Figure 4‑190: Left Ventricular Septal Pacing: Potential Application for Cardiac Resynchronization Therapy
Figure 4‑191: Quartet Lead and Resynchronization Therapy Options
Figure 4‑192: Attain Stability™ Quad Clinical Study
Figure 4‑193: The Efficacy of Single Coil Defibrillation Leads for Internal Cardioversion of Persistent Atrial Fibrillation
Figure 4‑194: Reverse RAMP Pacing to Terminate Ventricular Tachycardia (REV-RAMP)
Figure 4‑195: AXONE -Acute: Acute Assessment of a Micro Multipolar Lead for Enhanced Cardiac Resynchronization Therapy
Figure 4‑196: A Clinical Evaluation of the Durata or Optisure High Voltage Leads and Ellipse VR ICD Undergoing MRI, an Investigational Device Exemption (IDE) Study
Figure 4‑197: Acute Study to Collect Electrical Signals From the Heart Using a Special Lead
Figure 4‑198: RHYTHMIA vs CARTO in Redo Ablation Procedures for Atrial Fibrillation (MAP-AF)
Figure 4‑199: RHythmia mAPping and Signal acquisitiOn for Data analYsis (RHAPSODY)
Figure 4‑200: Cryoballoon vs. Rhythmia Guided Ablation for Recurrent AFib
Figure 4‑201: Esophageal 3D Mapping System for Cardiac Arrhythmias
Figure 4‑202: The Basel CardioInsightTM - 3D Mapping Study (BigMap)
Figure 4‑203: Non-Invasive 3D Mapping for Identifying Origin and Preferential Propagation of Ventricular Arrhythmias
Figure 4‑204: RADAR Clinical Trial
Figure 4‑205: EnSite™ HD Grid Catheter Mapping Study
Figure 4‑206: Clinical Utility and Validation of the Rhythmia Mapping System for the Treatment of Cardiac Arrhythmias
Figure 4‑207: Surface ECG Signal Recording for the Implantable Subcutaneous String Defibrillator (ISSD) Detection Algorithm Performance Assessment
Figure 4‑208: An Evaluation of the Safety and Performance of the CathVision Cube® System
Figure 4‑209: The Automated Calculation of AF Cycle Length and Complexity Using a Novel EP Recording System
Figure 4‑210: Surface Electrocardiogram (ECG) Signal Recording for Implantable Subcutaneous String Defibrillator (ISSD) Development
Figure 4‑211: Advanced Cardiac Therapeutics DiamondTemp TempeRAture-Controlled and Contact Sensing RF Ablation Clinical Trial for Atrial Fibrillation
Figure 4‑212: ICE Based Atrial Flutter Ablation Vs Conventional Fluoroscopy/Anatomical Mapping Based Ablation - ICE Flutter Study
Figure 4‑213: Philips Intracardiac Echocardiography (ICE) Clinical Registry
Figure 4‑214: Foresight Intracardiac Echocardiography (ICE) System
Figure 4‑215: INtra-procedural ultraSound Imaging During Isolation of the Pulmonary Veins
Figure 4‑216: EnSite Precision™ 2.0 Registry
Figure 4‑217: Foresight Intracardiac Echocardiography (ICE) System
Figure 4‑218: EPICADIA - Electrophysiologic Performance Investigation for CArdiac DIAgnosis
Figure 4‑219: Esophageal 3D Mapping System for Cardiac Arrhythmias: esoECG-3D
Figure 4‑220: EnSite™ HD Grid Catheter Mapping System for Advanced High Density Three-Dimensional Mapping in Non-Paroxysmal Atrial Fibrillation and Atrial Tachycardia
Figure 4‑221: DURABLE-I Study: Dielectric Unravelling of Radiofrequency ABLation Effectiveness
Figure 4‑222: FIRE AND ICE II Trial Pilot
Figure 4‑223: TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study (TactiCathPAS)
Figure 4‑224: Abbott Atrial Fibrillation Post Approval Study
Figure 4‑225: Cryotherapy Versus Radiofrequency Catheter Ablation Research Program
Figure 4‑226: Safety and Effectiveness Evaluation of the Multi-Electrode Radiofrequency Balloon Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation (STELLAR)
Figure 4‑227: Clinical Evaluation of the StablePoint Catheter and Force Sensing System for Paroxysmal Atrial Fibrillation (NEwTON AF)
Figure 4‑228: Clinical Study for Safety and Acute Performance Evaluation of the THERMOCOOL SMARTTOUCH® SF-5D System Used With Fast Ablation Mode in Treatment of Patients With Paroxysmal Atrial Fibrillation
Figure 4‑229: Comparison of Contact-force Monitoring Irrigated Tip Catheter and Mesh-like Irrigated Tip Catheter in Atrial Fibrillation Ablation: Prospective Randomized Trial (COMMIC Trial)
Figure 4‑230: Microfidelity (MIFI) Ablation Technology Versus Standard Ablation Catheter for Atrioventricular Nodal Ablation A Comparative Pilot Study of Time to Success
Figure 4‑231: Cardiovascular Magnetic Resonance-Guided Radiofrequency-Ablation for Atrial Flutter
Figure 4‑232: Advanced Cardiac Therapeutics DiamondTemp TempeRAture-Controlled and Contact Sensing RF Ablation Clinical Trial for Atrial Fibrillation
Figure 4‑233: CRyoAblation vs AntiaRrhythmic Drugs for Persistent Atrial Fibrillation Trial
Figure 4‑234: AtriCure CryoICE Lesions for Persistent and Long-standing Persistent Atrial Fibrillation Treatment (ICE-AFIB)
Figure 4‑235: FREEZE-AFIB Post-Market Study
Figure 4‑236: Cryoballoon Pulmonary Vein Isolation as First Line Treatment for Typical Atrial Flutter
Figure 4‑237: Ablation STrategies for Repeat PrOcedures in Patients With Atrial Fibrillation Recurrences (ASTRO AF)
Figure 4‑238: ArcticLine Feasibility Study
Figure 4‑239: A Prospective, Multicenter Investigation of the Adagio Cryoablation System in Patients With Atrial Fibrillation
Figure 4‑240: A Prospective Study of Medical Therapy Against Cryoballoon Ablation in Symptomatic Recent Onset Persistent Atrial Fibrilation
Figure 4‑241: STOP AF First: Cryoballoon Catheter Ablation in an Antiarrhythmic Drug Naive Paroxysmal Atrial Fibrillation
Figure 4‑242: A Comparison of Radiofrequency Catheter Ablation With or Without Contact-force and Cryoablation for Paroxysmal Atrial Fibrillation Ablation
Figure 4‑243: A Prospective, Multicenter, Investigation of the Adagio PolarStar System in Subjects With Atrial Flutter
Figure 4‑244: PV Cryoablation Efficacy Using Electrophysiological Endpoints and the New Generation ArticFont Advance ST Catheter (COR ADVANCE Study)
Figure 4‑245: STOP Persistent AF
Figure 4‑246: Cryoablation of Atrial Fibrillation in Patients With Severe Heart Failure
Figure 4‑247: Left Atrial Cryoablation Enhanced by Ganglionated Plexi Ablation in the Treatment of Atrial Fibrillation
Figure 4‑248: PV Cryoablation Efficacy Using Electrophysiological Endpoints and the New Generation ArticFont Advance ST Catheter (COR ADVANCE Study)
Figure 4‑249: CardioFocus vs. Contact Force Guided Pulmonary Vein Isolation in Paroxysmal Atrial Fibrillation
Figure 4‑250: Outcomes of Second-Generation Laser Balloon Ablation for Atrial Fibrillation (LIGHT-AF)
Figure 4‑251: Laser Ablation Study for trEatment of atRial Fibrillation (LASER)
Figure 5‑1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Global, 2018 – 2028 (US$M)
Figure 5‑2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Region, Global, 2018 – 2028 (US$M)
Figure 5‑3: Leading Competitors, Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Global, 2021 (1 of 2)
Figure 5‑4: Leading Competitors, Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, Global, 2021 (2 of 2)
Figure 5‑5: SWOT Analysis, Abbott (1 of 2)
Figure 5‑6: SWOT Analysis, Abbott (2 of 2)
Figure 5‑7: SWOT Analysis, Biosense Webster (1 of 2)
Figure 5‑8: SWOT Analysis, Biosense Webster (2 of 2)
Figure 5‑9: SWOT Analysis, Biotronik (1 of 2)
Figure 5‑10: SWOT Analysis, Biotronik (2 of 2)
Figure 5‑11: SWOT Analysis, Boston Scientific (1 of 2)
Figure 5‑12: SWOT Analysis, Boston Scientific (2 of 2)
Figure 5‑13: SWOT Analysis, GE Healthcare (1 of 2)
Figure 5‑14: SWOT Analysis, GE Healthcare (2 of 2)
Figure 5‑15: SWOT Analysis, Medtronic (1 of 2)
Figure 5‑16: SWOT Analysis, Medtronic (2 of 2)
Figure 5‑17: SWOT Analysis, MicroPort (1 of 2)
Figure 5‑18: SWOT Analysis, MicroPort (2 of 2)
Figure 6‑1: Pacemaker Procedures Covered
Figure 6‑2: Pacemaker Markets Covered
Figure 6‑3: Pacemaker Regions Covered, Global (1 of 2)
Figure 6‑4: Pacemaker Regions Covered, Global (2 of 2)
Figure 6‑5: Pacemaker Placement Procedures by Segment, Global, 2018 – 2028
Figure 6‑6: Pacemaker Placement Procedures by Region, Global, 2018 – 2028
Figure 6‑7: Pacemaker Placement Procedures by Country, North America, 2018 – 2028
Figure 6‑8: Pacemaker Placement Procedures by Country, Latin America, 2018 – 2028 (1 of 2)
Figure 6‑9: Pacemaker Placement Procedures by Country, Latin America, 2018 – 2028 (2 of 2)
Figure 6‑10: Pacemaker Placement Procedures by Country, Western Europe, 2018 – 2028
Figure 6‑11: Pacemaker Placement Procedures by Country, Central & Eastern Europe, 2018 – 2028 (1 of 2)
Figure 6‑12: Pacemaker Placement Procedures by Country, Central & Eastern Europe, 2018 – 2028 (2 of 2)
Figure 6‑13: Pacemaker Placement Procedures by Country, Middle East, 2018 – 2028
Figure 6‑14: Pacemaker Placement Procedures by Country, Asia-Pacific, 2018 – 2028 (1 of 3)
Figure 6‑15: Pacemaker Placement Procedures by Country, Asia-Pacific, 2018 – 2028 (2 of 3)
Figure 6‑16: Pacemaker Placement Procedures by Country, Asia-Pacific, 2018 – 2028 (3 of 3)
Figure 6‑17: Pacemaker Placement Procedures by Country, Africa, 2018 – 2028
Figure 6‑18: Initial Placement Pacemaker Procedures by Region, Global, 2018 – 2028
Figure 6‑19: Initial Placement Pacemaker Procedures by Country, North America, 2018 – 2028
Figure 6‑20: Initial Placement Pacemaker Procedures by Country, Latin America, 2018 – 2028 (1 of 2)
Figure 6‑21: Initial Placement Pacemaker Procedures by Country, Latin America, 2018 – 2028 (2 of 2)
Figure 6‑22: Initial Placement Pacemaker Procedures by Country, Western Europe, 2018 – 2028
Figure 6‑23: Initial Placement Pacemaker Procedures by Country, Central & Eastern Europe, 2018 – 2028 (1 of 2)
Figure 6‑24: Initial Placement Pacemaker Procedures by Country, Central & Eastern Europe, 2018 – 2028 (2 of 2)
Figure 6‑25: Initial Placement Pacemaker Procedures by Country, Middle East, 2018 – 2028
Figure 6‑26: Initial Placement Pacemaker Procedures by Country, Asia-Pacific, 2018 – 2028 (1 of 3)
Figure 6‑27: Initial Placement Pacemaker Procedures by Country, Asia-Pacific, 2018 – 2028 (2 of 3)
Figure 6‑28: Initial Placement Pacemaker Procedures by Country, Asia-Pacific, 2018 – 2028 (3 of 3)
Figure 6‑29: Initial Placement Pacemaker Procedures by Country, Africa, 2018 – 2028
Figure 6‑30: Replacement Pacemaker Procedures by Region, Global, 2018 – 2028
Figure 6‑31: Replacement Pacemaker Procedures by Country, North America, 2018 – 2028
Figure 6‑32: Replacement Pacemaker Procedures by Country, Latin America, 2018 – 2028 (1 of 2)
Figure 6‑33: Replacement Pacemaker Procedures by Country, Latin America, 2018 – 2028 (2 of 2)
Figure 6‑34: Replacement Pacemaker Procedures by Country, Western Europe, 2018 – 2028
Figure 6‑35: Replacement Pacemaker Procedures by Country, Central & Eastern Europe, 2018 – 2028 (1 of 2)
Figure 6‑36: Replacement Pacemaker Procedures by Country, Central & Eastern Europe, 2018 – 2028 (2 of 2)
Figure 6‑37: Replacement Pacemaker Procedures by Country, Middle East, 2018 – 2028
Figure 6‑38: Replacement Pacemaker Procedures by Country, Asia-Pacific, 2018 – 2028 (1 of 3)
Figure 6‑39: Replacement Pacemaker Procedures by Country, Asia-Pacific, 2018 – 2028 (2 of 3)
Figure 6‑40: Replacement Pacemaker Procedures by Country, Asia-Pacific, 2018 – 2028 (2 of 3)
Figure 6‑41: Replacement Pacemaker Procedures by Country, Africa, 2018 – 2028
Figure 6‑42: Pacemaker Market by Segment, Global, 2018 – 2028 (US$M)
Figure 6‑43: Pacemaker Market by Region, Global, 2018 – 2028 (US$M)
Figure 6‑44: Pacemaker Market, Global, 2018 – 2028
Figure 6‑45: Units Sold by Region, Pacemaker Market, Global, 2018 – 2028
Figure 6‑46: Average Selling Price by Region, Pacemaker Market, Global, 2018 – 2028 (US$)
Figure 6‑47: Market Value by Region, Pacemaker Market, Global, 2018 – 2028 (US$M)
Figure 6‑48: Single-Chamber Pacemaker Market by Segment, Global, 2018 – 2028 (US$M)
Figure 6‑49: Single-Chamber Pacemaker Market, Global, 2018 – 2028
Figure 6‑50: Units Sold by Region, Single-Chamber Pacemaker Market, Global, 2018 – 2028
Figure 6‑51: Average Selling Price by Region, Single-Chamber Pacemaker Market, Global, 2018 – 2028 (US$)
Figure 6‑52: Market Value by Region, Single-Chamber Pacemaker Market, Global, 2018 – 2028 (US$M)
Figure 6‑53: Initial Placement Single-Chamber Pacemaker Market, Global, 2018 – 2028
Figure 6‑54: Units Sold by Region, Initial Placement Single-Chamber Pacemaker Market, Global, 2018 – 2028
Figure 6‑55: Average Selling Price by Region, Initial Placement Single-Chamber Pacemaker Market, Global, 2018 – 2028 (US$)
Figure 6‑56: Market Value by Region, Initial Placement Single-Chamber Pacemaker Market, Global, 2018 – 2028 (US$M)
Figure 6‑57: Replacement Single-Chamber Pacemaker Market, Global, 2018 – 2028
Figure 6‑58: Units Sold by Region, Replacement Single-Chamber Pacemaker Market, Global, 2018 – 2028
Figure 6‑59: Average Selling Price by Region, Replacement Single-Chamber Pacemaker Market, Global, 2018 – 2028 (US$)
Figure 6‑60: Market Value by Region, Replacement Single-Chamber Pacemaker Market, Global, 2018 – 2028 (US$M)
Figure 6‑61: Dual-Chamber Pacemaker Market by Segment, Global, 2018 – 2028 (US$M)
Figure 6‑62: Dual-Chamber Pacemaker Market, Global, 2018 – 2028
Figure 6‑63: Units Sold by Region, Dual-Chamber Pacemaker Market, Global, 2018 – 2028
Figure 6‑64: Average Selling Price by Region, Dual-Chamber Pacemaker Market, Global, 2018 – 2028 (US$)
Figure 6‑65: Market Value by Region, Dual-Chamber Pacemaker Market, Global, 2018 – 2028 (US$M)
Figure 6‑66: Initial Placement Dual-Chamber Pacemaker Market, Global, 2018 – 2028
Figure 6‑67: Units Sold by Region, Initial Placement Dual-Chamber Pacemaker Market, Global, 2018 – 2028
Figure 6‑68: Average Selling Price by Region, Initial Placement Dual-Chamber Pacemaker Market, Global, 2018 – 2028 (US$)
Figure 6‑69: Market Value by Region, Initial Placement Dual-Chamber Pacemaker Market, Global, 2018 – 2028 (US$M)
Figure 6‑70: Replacement Dual-Chamber Pacemaker Market, Global, 2018 – 2028
Figure 6‑71: Units Sold by Region, Replacement Dual-Chamber Pacemaker Market, Global, 2018 – 2028
Figure 6‑72: Average Selling Price by Region, Replacement Dual-Chamber Pacemaker Market, Global, 2018 – 2028 (US$)
Figure 6‑73: Market Value by Region, Replacement Dual-Chamber Pacemaker Market, Global, 2018 – 2028 (US$M)
Figure 6‑74: Leadless Pacemaker Market by Segment, Global, 2018 – 2028 (US$M)
Figure 6‑75: Leadless Pacemaker Market, Global, 2018 – 2028
Figure 6‑76: Units Sold by Region, Leadless Pacemaker Market, Global, 2018 – 2028
Figure 6‑77: Average Selling Price by Region, Leadless Pacemaker Market, Global, 2018 – 2028 (US$)
Figure 6‑78: Market Value by Region, Leadless Pacemaker Market, Global, 2018 – 2028 (US$M)
Figure 6‑79: Initial Placement Leadless Pacemaker Market, Global, 2018 – 2028
Figure 6‑80: Units Sold by Region, Initial Placement Leadless Pacemaker Market, Global, 2018 – 2028
Figure 6‑81: Average Selling Price by Region, Initial Placement Leadless Pacemaker Market, Global, 2018 – 2028 (US$)
Figure 6‑82: Market Value by Region, Initial Placement Leadless Pacemaker Market, Global, 2018 – 2028 (US$M)
Figure 6‑83: Replacement Leadless Pacemaker Market, Global, 2018 – 2028
Figure 6‑84: Units Sold by Region, Replacement Leadless Pacemaker Market, Global, 2018 – 2028
Figure 6‑85: Average Selling Price by Region, Replacement Leadless Pacemaker Market, Global, 2018 – 2028 (US$)
Figure 6‑86: Market Value by Region, Replacement Leadless Pacemaker Market, Global, 2018 – 2028 (US$M)
Figure 6‑87: Leading Competitors, Pacemaker Market, Global, 2021
Figure 6‑88: Leading Competitors by Region, Pacemaker Market, Global, 2021
Figure 6‑89: Leading Competitors by Region, Single-Chamber Pacemaker Market, Global, 2021
Figure 6‑90: Leading Competitors by Region, Dual-Chamber Pacemaker Market, Global, 2021
Figure 7‑1: ICD Procedures Covered
Figure 7‑2: ICD Markets Covered
Figure 7‑3: ICD Regions Covered, Global (1 of 2)
Figure 7‑4: ICD Regions Covered, Global (2 of 2)
Figure 7‑5: ICD Placement Procedures by Segment, Global, 2018 – 2028
Figure 7‑6: ICD Placement Procedures by Region, Global, 2018 – 2028
Figure 7‑7: ICD Placement Procedures by Country, North America, 2018 – 2028
Figure 7‑8: ICD Placement Procedures by Country, Latin America, 2018 – 2028 (1 of 2)
Figure 7‑9: ICD Placement Procedures by Country, Latin America, 2018 – 2028 (2 of 2)
Figure 7‑10: ICD Placement Procedures by Country, Western Europe, 2018 – 2028
Figure 7‑11: ICD Placement Procedures by Country, Central & Eastern Europe, 2018 – 2028 (1 of 2)
Figure 7‑12: ICD Placement Procedures by Country, Central & Eastern Europe, 2018 – 2028 (2 of 2)
Figure 7‑13: ICD Placement Procedures by Country, Middle East, 2018 – 2028
Figure 7‑14: ICD Placement Procedures by Country, Asia-Pacific, 2018 – 2028 (1 of 3)
Figure 7‑15: ICD Placement Procedures by Country, Asia-Pacific, 2018 – 2028 (2 of 3)
Figure 7‑16: ICD Placement Procedures by Country, Asia-Pacific, 2018 – 2028 (3 of 3)
Figure 7‑17: ICD Placement Procedures by Country, Africa, 2018 – 2028
Figure 7‑18: Initial Placement ICD Procedures by Region, Global, 2018 – 2028
Figure 7‑19: Initial Placement ICD Procedures by Country, North America, 2018 – 2028
Figure 7‑20: Initial Placement ICD Procedures by Country, Latin America, 2018 – 2028 (1 of 2)
Figure 7‑21: Initial Placement ICD Procedures by Country, Latin America, 2018 – 2028 (2 of 2)
Figure 7‑22: Initial Placement ICD Procedures by Country, Western Europe, 2018 – 2028
Figure 7‑23: Initial Placement ICD Procedures by Country, Central & Eastern Europe, 2018 – 2028 (1 of 2)
Figure 7‑24: Initial Placement ICD Procedures by Country, Central & Eastern Europe, 2018 – 2028 (2 of 2)
Figure 7‑25: Initial Placement ICD Procedures by Country, Middle East, 2018 – 2028
Figure 7‑26: Initial Placement ICD Procedures by Country, Asia-Pacific, 2018 – 2028 (1 of 3)
Figure 7‑27: Initial Placement ICD Procedures by Country, Asia-Pacific, 2018 – 2028 (2 of 3)
Figure 7‑28: Initial Placement ICD Procedures by Country, Asia-Pacific, 2018 – 2028 (3 of 3)
Figure 7‑29: Initial Placement ICD Procedures by Country, Africa, 2018 – 2028
Figure 7‑30: Replacement ICD Procedures by Region, Global, 2018 – 2028
Figure 7‑31: Replacement ICD Procedures by Country, North America, 2018 – 2028
Figure 7‑32: Replacement ICD Procedures by Country, Latin America, 2018 – 2028 (1 of 2)
Figure 7‑33: Replacement ICD Procedures by Country, Latin America, 2018 – 2028 (2 of 2)
Figure 7‑34: Replacement ICD Procedures by Country, Western Europe, 2018 – 2028
Figure 7‑35: Replacement ICD Procedures by Country, Central & Eastern Europe, 2018 – 2028 (1 of 2)
Figure 7‑36: Replacement ICD Procedures by Country, Central & Eastern Europe, 2018 – 2028 (2 of 2)
Figure 7‑37: Replacement ICD Procedures by Country, Middle East, 2018 – 2028
Figure 7‑38: Replacement ICD Procedures by Country, Asia-Pacific, 2018 – 2028 (1 of 3)
Figure 7‑39: Replacement ICD Procedures by Country, Asia-Pacific, 2018 – 2028 (2 of 3)
Figure 7‑40: Replacement ICD Procedures by Country, Asia-Pacific, 2018 – 2028 (3 of 3)
Figure 7‑41: Replacement ICD Procedures by Country, Africa, 2018 – 2028
Figure 7‑42: ICD Market by Segment, Global, 2018 – 2028 (US$M)
Figure 7‑43: ICD Market by Region, Global, 2018 – 2028 (US$M)
Figure 7‑44: ICD Market, Global, 2018 – 2028
Figure 7‑45: Units Sold by Region, ICD Market, Global, 2018 – 2028
Figure 7‑46: Average Selling Price by Region, ICD Market, Global, 2018 – 2028 (US$)
Figure 7‑47: Market Value by Region, ICD Market, Global, 2018 – 2028 (US$M)
Figure 7‑48: Single-Chamber ICD Market by Segment, Global, 2018 – 2028 (US$M)
Figure 7‑49: Single-Chamber ICD Market, Global, 2018 – 2028
Figure 7‑50: Units Sold by Region, Single-Chamber ICD Market, Global, 2018 – 2028
Figure 7‑51: Average Selling Price by Region, Single-Chamber ICD Market, Global, 2018 – 2028 (US$)
Figure 7‑52: Market Value by Region, Single-Chamber ICD Market, Global, 2018 – 2028 (US$M)
Figure 7‑53: Initial Placement Single-Chamber ICD Market, Global, 2018 – 2028
Figure 7‑54: Units Sold by Region, Initial Placement Single-Chamber ICD Market, Global, 2018 – 2028
Figure 7‑55: Average Selling Price by Region, Initial Placement Single-Chamber ICD Market, Global, 2018 – 2028 (US$)
Figure 7‑56: Market Value by Region, Initial Placement Single-Chamber ICD Market, Global, 2018 – 2028 (US$M)
Figure 7‑57: Replacement Single-Chamber ICD Market, Global, 2018 – 2028
Figure 7‑58: Units Sold by Region, Replacement Single-Chamber ICD Market, Global, 2018 – 2028
Figure 7‑59: Average Selling Price by Region, Replacement Single-Chamber ICD Market, Global, 2018 – 2028 (US$)
Figure 7‑60: Market Value by Region, Replacement Single-Chamber ICD Market, Global, 2018 – 2028 (US$M)
Figure 7‑61: Dual-Chamber ICD Market by Segment, Global, 2018 – 2028 (US$M)
Figure 7‑62: Dual-Chamber ICD Market, Global, 2018 – 2028
Figure 7‑63: Units Sold by Region, Dual-Chamber ICD Market, Global, 2018 – 2028
Figure 7‑64: Average Selling Price by Region, Dual-Chamber ICD Market, Global, 2018 – 2028 (US$)
Figure 7‑65: Market Value by Region, Dual-Chamber ICD Market, Global, 2018 – 2028 (US$M)
Figure 7‑66: Initial Placement Dual-Chamber ICD Market, Global, 2018 – 2028
Figure 7‑67: Units Sold by Region, Initial Placement Dual-Chamber ICD Market, Global, 2018 – 2028
Figure 7‑68: Average Selling Price by Region, Initial Placement Dual-Chamber ICD Market, Global, 2018 – 2028 (US$)
Figure 7‑69: Market Value by Region, Initial Placement Dual-Chamber ICD Market, Global, 2018 – 2028 (US$M)
Figure 7‑70: Replacement Dual-Chamber ICD Market, Global, 2018 – 2028
Figure 7‑71: Units Sold by Region, Replacement Dual-Chamber ICD Market, Global, 2018 – 2028
Figure 7‑72: Average Selling Price by Region, Replacement Dual-Chamber ICD Market, Global, 2018 – 2028 (US$)
Figure 7‑73: Market Value by Region, Replacement Dual-Chamber ICD Market, Global, 2018 – 2028 (US$M)
Figure 7‑74: S-ICD Market by Segment, Global, 2018 – 2028 (US$M)
Figure 7‑75: S-ICD Market, Global, 2018 – 2028
Figure 7‑76: Units Sold by Region, S-ICD Market, Global, 2018 – 2028
Figure 7‑77: Average Selling Price by Region, S-ICD Market, Global, 2018 – 2028 (US$)
Figure 7‑78: Market Value by Region, S-ICD Market, Global, 2018 – 2028 (US$M)
Figure 7‑79: Initial Placement S-ICD Market, Global, 2018 – 2028
Figure 7‑80: Units Sold by Region, Initial Placement S-ICD Market, Global, 2018 – 2028
Figure 7‑81: Average Selling Price by Region, Initial Placement S-ICD Market, Global, 2018 – 2028 (US$)
Figure 7‑82: Market Value by Region, Initial Placement S-ICD Market, Global, 2018 – 2028 (US$M)
Figure 7‑83: Replacement S-ICD Market, Global, 2018 – 2028
Figure 7‑84: Units Sold by Region, Replacement S-ICD Market, Global, 2018 – 2028
Figure 7‑85: Average Selling Price by Region, Replacement S-ICD Market, Global, 2018 – 2028 (US$)
Figure 7‑86: Market Value by Region, Replacement S-ICD Market, Global, 2018 – 2028 (US$M)
Figure 7‑87: Leading Competitors, ICD Market, Global, 2021
Figure 7‑88: Leading Competitors by Region, ICD Market, Global, 2021
Figure 7‑89: Leading Competitors by Region, Single-Chamber ICD Market, Global, 2021
Figure 7‑90: Leading Competitors by Region, Dual-Chamber ICD Market, Global, 2021
Figure 8‑1: CRT Device Procedures Covered
Figure 8‑2: CRT Device Markets Covered
Figure 8‑3: CRT Device Regions Covered, Global (1 of 2)
Figure 8‑4: CRT Device Regions Covered, Global (2 of 2)
Figure 8‑5: CRT Placement Procedures by Segment, Global, 2018 – 2028
Figure 8‑6: CRT Placement Procedures by Region, Global, 2018 – 2028
Figure 8‑7: CRT Placement Procedures by Country, North America, 2018 – 2028
Figure 8‑8: CRT Placement Procedures by Country, Latin America, 2018 – 2028 (1 of 2)
Figure 8‑9: CRT Placement Procedures by Country, Latin America, 2018 – 2028 (2 of 2)
Figure 8‑10: CRT Placement Procedures by Country, Western Europe, 2018 – 2028
Figure 8‑11: CRT Placement Procedures by Country, Central & Eastern Europe, 2018 – 2028 (1 of 2)
Figure 8‑12: CRT Placement Procedures by Country, Central & Eastern Europe, 2018 – 2028 (2 of 2)
Figure 8‑13: CRT Placement Procedures by Country, Middle East, 2018 – 2028
Figure 8‑14: CRT Placement Procedures by Country, Asia-Pacific, 2018 – 2028 (1 of 3)
Figure 8‑15: CRT Placement Procedures by Country, Asia-Pacific, 2018 – 2028 (2 of 3)
Figure 8‑16: CRT Placement Procedures by Country, Asia-Pacific, 2018 – 2028 (3 of 3)
Figure 8‑17: CRT Placement Procedures by Country, Africa, 2018 – 2028
Figure 8‑18: Initial Placement CRT Procedures by Region, Global, 2018 – 2028
Figure 8‑19: Initial Placement CRT Procedures by Country, North America, 2018 – 2028
Figure 8‑20: Initial Placement CRT Procedures by Country, Latin America, 2018 – 2028 (1 of 2)
Figure 8‑21: Initial Placement CRT Procedures by Country, Latin America, 2018 – 2028 (2 of 2)
Figure 8‑22: Initial Placement CRT Procedures by Country, Western Europe, 2018 – 2028
Figure 8‑23: Initial Placement CRT Procedures by Country, Central & Eastern Europe, 2018 – 2028 (1 of 2)
Figure 8‑24: Initial Placement CRT Procedures by Country, Central & Eastern Europe, 2018 – 2028 (2 of 2)
Figure 8‑25: Initial Placement CRT Procedures by Country, Middle East, 2018 – 2028
Figure 8‑26: Initial Placement CRT Procedures by Country, Asia-Pacific, 2018 – 2028 (1 of 3)
Figure 8‑27: Initial Placement CRT Procedures by Country, Asia-Pacific, 2018 – 2028 (2 of 3)
Figure 8‑28: Initial Placement CRT Procedures by Country, Asia-Pacific, 2018 – 2028 (3 of 3)
Figure 8‑29: Initial Placement CRT Procedures by Country, Africa, 2018 – 2028
Figure 8‑30: Replacement CRT Procedures by Region, Global, 2018 – 2028
Figure 8‑31: Replacement CRT Procedures by Country, North America, 2018 – 2028
Figure 8‑32: Replacement CRT Procedures by Country, Latin America, 2018 – 2028 (1 of 2)
Figure 8‑33: Replacement CRT Procedures by Country, Latin America, 2018 – 2028 (2 of 2)
Figure 8‑34: Replacement CRT Procedures by Country, Western Europe, 2018 – 2028
Figure 8‑35: Replacement CRT Procedures by Country, Central & Eastern Europe, 2018 – 2028 (1 of 2)
Figure 8‑36: Replacement CRT Procedures by Country, Central & Eastern Europe, 2018 – 2028 (2 of 2)
Figure 8‑37: Replacement CRT Procedures by Country, Middle East, 2018 – 2028
Figure 8‑38: Replacement CRT Procedures by Country, Asia-Pacific, 2018 – 2028 (1 of 3)
Figure 8‑39: Replacement CRT Procedures by Country, Asia-Pacific, 2018 – 2028 (2 of 3)
Figure 8‑40: Replacement CRT Procedures by Country, Asia-Pacific, 2018 – 2028 (3 of 3)
Figure 8‑41: Replacement CRT Procedures by Country, Africa, 2018 – 2028
Figure 8‑42: CRT Device Market by Segment, Global, 2018 – 2028 (US$M)
Figure 8‑43: CRT Device Market by Region, Global, 2018 – 2028 (US$M)
Figure 8‑44: CRT Device Market, Global, 2018 – 2028
Figure 8‑45: Units Sold by Region, CRT Device Market, Global, 2018 – 2028
Figure 8‑46: Average Selling Price by Region, CRT Device Market, Global, 2018 – 2028 (US$)
Figure 8‑47: Market Value by Region, CRT Device Market, Global, 2018 – 2028 (US$M)
Figure 8‑48: CRT-P Market by Segment, Global, 2018 – 2028 (US$M)
Figure 8‑49: CRT-P Market, Global, 2018 – 2028
Figure 8‑50: Units Sold by Region, CRT-P Market, Global, 2018 – 2028
Figure 8‑51: Average Selling Price by Region, CRT-P Market, Global, 2018 – 2028 (US$)
Figure 8‑52: Market Value by Region, CRT-P Market, Global, 2018 – 2028 (US$M)
Figure 8‑53: Initial Placement CRT-P Market, Global, 2018 – 2028
Figure 8‑54: Units Sold by Region, Initial Placement CRT-P Market, Global, 2018 – 2028
Figure 8‑55: Average Selling Price by Region, Initial Placement CRT-P Market, Global, 2018 – 2028 (US$)
Figure 8‑56: Market Value by Region, Initial Placement CRT-P Market, Global, 2018 – 2028 (US$M)
Figure 8‑57: Replacement CRT-P Market, Global, 2018 – 2028
Figure 8‑58: Units Sold by Region, Replacement CRT-P Market, Global, 2018 – 2028
Figure 8‑59: Average Selling Price by Region, Replacement CRT-P Market, Global, 2018 – 2028 (US$)
Figure 8‑60: Market Value by Region, Replacement CRT-P Market, Global, 2018 – 2028 (US$M)
Figure 8‑61: CRT-D Market by Segment, Global, 2018 – 2028 (US$M)
Figure 8‑62: CRT-D Market, Global, 2018 – 2028
Figure 8‑63: Units Sold by Region, CRT-D Market, Global, 2018 – 2028
Figure 8‑64: Average Selling Price by Region, CRT-D Market, Global, 2018 – 2028 (US$)
Figure 8‑65: Market Value by Region, CRT-D Market, Global, 2018 – 2028 (US$M)
Figure 8‑66: Initial Placement CRT-D Market, Global, 2018 – 2028
Figure 8‑67: Units Sold by Region, Initial Placement CRT-D Market, Global, 2018 – 2028
Figure 8‑68: Average Selling Price by Region, Initial Placement CRT-D Market, Global, 2018 – 2028 (US$)
Figure 8‑69: Market Value by Region, Initial Placement CRT-D Market, Global, 2018 – 2028 (US$M)
Figure 8‑70: Replacement CRT-D Market, Global, 2018 – 2028
Figure 8‑71: Units Sold by Region, Replacement CRT-D Market, Global, 2018 – 2028
Figure 8‑72: Average Selling Price by Region, Replacement CRT-D Market, Global, 2018 – 2028 (US$)
Figure 8‑73: Market Value by Region, Replacement CRT-D Market, Global, 2018 – 2028 (US$M)
Figure 8‑74: Leading Competitors, CRT Device Market, Global, 2021
Figure 8‑75: Leading Competitors by Region, CRT Device Market, Global, 2021
Figure 8‑76: Leading Competitors by Region, CRT-P Market, Global, 2021
Figure 8‑77: Leading Competitors by Region, CRT-DMarket, Global, 2021
Figure 9‑1: Cardiac Lead Markets Covered
Figure 9‑2: Cardiac Lead Regions Covered, Global (1 of 2)
Figure 9‑3: Cardiac Lead Regions Covered, Global (2 of 2)
Figure 9‑4: Cardiac Lead Market by Segment, Global, 2018 – 2028 (US$M)
Figure 9‑5: Cardiac Lead Market by Region, Global, 2018 – 2028 (US$M)
Figure 9‑6: Cardiac Lead Market, Global, 2018 – 2028
Figure 9‑7: Units Sold by Region, Cardiac Lead Market, Global, 2018 – 2028
Figure 9‑8: Average Selling Price by Region, Cardiac Lead Market, Global, 2018 – 2028 (US$)
Figure 9‑9: Market Value by Region, Cardiac Lead Market, Global, 2018 – 2028 (US$M)
Figure 9‑10: Pacing Lead Market, Global, 2018 – 2028
Figure 9‑11: Units Sold by Region, Pacing Lead Market, Global, 2018 – 2028
Figure 9‑12: Average Selling Price by Region, Pacing Lead Market, Global, 2018 – 2028 (US$)
Figure 9‑13: Market Value by Region, Pacing Lead Market, Global, 2018 – 2028 (US$M)
Figure 9‑14: Defibrillation Lead Market, Global, 2018 – 2028
Figure 9‑15: Units Sold by Region, Defibrillation Lead Market, Global, 2018 – 2028
Figure 9‑16: Average Selling Price by Region, Defibrillation Lead Market, Global, 2018 – 2028 (US$)
Figure 9‑17: Market Value by Region, Defibrillation Lead Market, Global, 2018 – 2028 (US$M)
Figure 9‑18: LV Lead Market, Global, 2018 – 2028
Figure 9‑19: Units Sold by Region, LV Lead Market, Global, 2018 – 2028
Figure 9‑20: Average Selling Price by Region, LV Lead Market, Global, 2018 – 2028 (US$)
Figure 9‑21: Market Value by Region, LV Lead Market, Global, 2018 – 2028 (US$M)
Figure 9‑22: Leading Competitors, Cardiac Lead Market, Global, 2021
Figure 9‑23: Leading Competitors by Region, Cardiac Lead Market, Global, 2021
Figure 9‑24: Leading Competitors by Region, Pacing Lead Market, Global, 2021
Figure 9‑25: Leading Competitors by Region, Defibrillation Lead Market, Global, 2021
Figure 9‑26: Leading Competitors by Region, LV Lead Market, Global, 2021
Figure 10‑1: Implantable Loop Recorder Regions Covered, Global (1 of 2)
Figure 10‑2: Implantable Loop Recorder Regions Covered, Global (2 of 2)
Figure 10‑3: Implantable Loop Recorder Placement Procedures by Region, Global, 2018 – 2028
Figure 10‑4: Implantable Loop Recorder Placement Procedures by Country, North America, 2018 – 2028
Figure 10‑5: Implantable Loop Recorder Placement Procedures by Country, Latin America, 2018 – 2028 (1 of 2)
Figure 10‑6: Implantable Loop Recorder Placement Procedures by Country, Latin America, 2018 – 2028 (2 of 2)
Figure 10‑7: Implantable Loop Recorder Placement Procedures by Country, Western Europe, 2018 – 2028
Figure 10‑8: Implantable Loop Recorder Placement Procedures by Country, Central & Eastern Europe, 2018 – 2028 (1 of 2)
Figure 10‑9: Implantable Loop Recorder Placement Procedures by Country, Central & Eastern Europe, 2018 – 2028 (2 of 2)
Figure 10‑10: Implantable Loop Recorder Placement Procedures by Country, Middle East, 2018 – 2028
Figure 10‑11: Implantable Loop Recorder Placement Procedures by Country, Asia-Pacific, 2018 – 2028 (1 of 3)
Figure 10‑12: Implantable Loop Recorder Placement Procedures by Country, Asia-Pacific, 2018 – 2028 (2 of 3)
Figure 10‑13: Implantable Loop Recorder Placement Procedures by Country, Asia-Pacific, 2018 – 2028 (3 of 3)
Figure 10‑14: Implantable Loop Recorder Placement Procedures by Country, Africa, 2018 – 2028
Figure 10‑15: Implantable Loop Recorder Market, Global, 2018 – 2028
Figure 10‑16: Units Sold by Region, Implantable Loop Recorder Market, Global, 2018 – 2028
Figure 10‑17: Average Selling Price by Region, Implantable Loop Recorder Market, Global, 2018 – 2028 (US$)
Figure 10‑18: Market Value by Region, Implantable Loop Recorder Market, Global, 2018 – 2028 (US$M)
Figure 10‑19: Leading Competitors, Implantable Loop Recorder Market, Global, 2021
Figure 11‑1: Electrophysiology Lab System Markets Covered
Figure 11‑2: Electrophysiology Lab System Regions Covered, Global (1 of 2)
Figure 11‑3: Electrophysiology Lab System Regions Covered, Global (2 of 2)
Figure 11‑4: Electrophysiology Lab System Market by Segment, Global, 2018 – 2028 (US$M)
Figure 11‑5: Electrophysiology Lab System Market by Region, Global, 2018 – 2028 (US$M)
Figure 11‑6: Electrophysiology Lab System Market, Global, 2018 – 2028
Figure 11‑7: Units Sold by Region, Electrophysiology Lab System Market, Global, 2018 – 2028
Figure 11‑8: Average Selling Price by Region, Electrophysiology Lab System Market, Global, 2018 – 2028 (US$)
Figure 11‑9: Market Value by Region, Electrophysiology Lab System Market, Global, 2018 – 2028 (US$M)
Figure 11‑10: 3D Mapping System Market, Global, 2018 – 2028
Figure 11‑11: Units Sold by Region, 3D Mapping System Market, Global, 2018 – 2028
Figure 11‑12: Average Selling Price by Region, 3D Mapping System Market, Global, 2018 – 2028 (US$)
Figure 11‑13: Market Value by Region, 3D Mapping System Market, Global, 2018 – 2028 (US$M)
Figure 11‑14: EP Recording System Market, Global, 2018 – 2028
Figure 11‑15: Units Sold by Region, EP Recording System Market, Global, 2018 – 2028
Figure 11‑16: Average Selling Price by Region, EP Recording System Market, Global, 2018 – 2028 (US$)
Figure 11‑17: Market Value by Region, EP Recording System Market, Global, 2018 – 2028 (US$M)
Figure 11‑18: Leading Competitors, Electrophysiology Lab System Market, Global, 2021
Figure 12‑1: Diagnostic Electrophysiology Catheter Markets Covered
Figure 12‑2: Diagnostic Electrophysiology Catheter Regions Covered, Global (1 of 2)
Figure 12‑3: Diagnostic Electrophysiology Catheter Regions Covered, Global (2 of 2)
Figure 12‑4: Diagnostic Electrophysiology Procedures by Region, Global, 2018 – 2028
Figure 12‑5: Diagnostic Electrophysiology Procedures by Country, North America, 2018 – 2028
Figure 12‑6: Diagnostic Electrophysiology Procedures by Country, Latin America, 2018 – 2028 (1 of 2)
Figure 12‑7: Diagnostic Electrophysiology Procedures by Country, Latin America, 2018 – 2028 (2 of 2)
Figure 12‑8: Diagnostic Electrophysiology Procedures by Country, Western Europe, 2018 – 2028
Figure 12‑9: Diagnostic Electrophysiology Procedures by Country, Central & Eastern Europe, 2018 – 2028 (1 of 2)
Figure 12‑10: Diagnostic Electrophysiology Procedures by Country, Central & Eastern Europe, 2018 – 2028 (2 of 2)
Figure 12‑11: Diagnostic Electrophysiology Procedures by Country, Middle East, 2018 – 2028
Figure 12‑12: Diagnostic Electrophysiology Procedures by Country, Asia-Pacific, 2018 – 2028 (1 of 3)
Figure 12‑13: Diagnostic Electrophysiology Procedures by Country, Asia-Pacific, 2018 – 2028 (2 of 3)
Figure 12‑14: Diagnostic Electrophysiology Procedures by Country, Asia-Pacific, 2018 – 2028 (3 of 3)
Figure 12‑15: Diagnostic Electrophysiology Procedures by Country, Africa, 2018 – 2028
Figure 12‑16: Diagnostic Electrophysiology Catheter Market by Segment, Global, 2018 – 2028 (US$M)
Figure 12‑17: Diagnostic Electrophysiology Catheter Market by Region, Global, 2018 – 2028 (US$M)
Figure 12‑18: Diagnostic Electrophysiology Catheter Market, Global, 2018 – 2028
Figure 12‑19: Units Sold by Region, Diagnostic Electrophysiology Catheter Market, Global, 2018 – 2028
Figure 12‑20: Average Selling Price by Region, Diagnostic Electrophysiology Catheter Market, Global, 2018 – 2028 (US$)
Figure 12‑21: Market Value by Region, Diagnostic Electrophysiology Catheter Market, Global, 2018 – 2028 (US$M)
Figure 12‑22: Conventional Electrophysiology Catheter Market, Global, 2018 – 2028
Figure 12‑23: Units Sold by Region, Conventional Electrophysiology Catheter Market, Global, 2018 – 2028
Figure 12‑24: Average Selling Price by Region, Conventional Electrophysiology Catheter Market, Global, 2018 – 2028 (US$)
Figure 12‑25: Market Value by Region, Conventional Electrophysiology Catheter Market, Global, 2018 – 2028 (US$M)
Figure 12‑26: Advanced Electrophysiology Catheter Market, Global, 2018 – 2028
Figure 12‑27: Units Sold by Region, Advanced Electrophysiology Catheter Market, Global, 2018 – 2028
Figure 12‑28: Average Selling Price by Region, Advanced Electrophysiology Catheter Market, Global, 2018 – 2028 (US$)
Figure 12‑29: Market Value by Region, Advanced Electrophysiology Catheter Market, Global, 2018 – 2028 (US$M)
Figure 12‑30: ICE Catheter Market, Global, 2018 – 2028
Figure 12‑31: Units Sold by Region, ICE Catheter Market, Global, 2018 – 2028
Figure 12‑32: Average Selling Price by Region, ICE Catheter Market, Global, 2018 – 2028 (US$)
Figure 12‑33: Market Value by Region, ICE Catheter Market, Global, 2018 – 2028 (US$M)
Figure 12‑34: Leading Competitors, Diagnostic Electrophysiology Catheter Market, Global, 2021
Figure 13‑1: Cardiac Ablation Catheter Procedures Covered
Figure 13‑2: Cardiac Ablation Catheter Markets Covered
Figure 13‑3: Cardiac Ablation Catheter Regions Covered, Global (1 of 2)
Figure 13‑4: Cardiac Ablation Catheter Regions Covered, Global (2 of 2)
Figure 13‑5: Cardiac Ablation Procedures by Segment, Global, 2018 – 2028
Figure 13‑6: Cardiac Ablation Procedures by Region, Global, 2018 – 2028
Figure 13‑7: Cardiac Ablation Procedures by Country, North America, 2018 – 2028
Figure 13‑8: Cardiac Ablation Procedures by Country, Latin America, 2018 – 2028 (1 of 2)
Figure 13‑9: Cardiac Ablation Procedures by Country, Latin America, 2018 – 2028 (2 of 2)
Figure 13‑10: Cardiac Ablation Procedures by Country, Western Europe, 2018 – 2028
Figure 13‑11: Cardiac Ablation Procedures by Country, Central & Eastern Europe, 2018 – 2028 (1 of 2)
Figure 13‑12: Cardiac Ablation Procedures by Country, Central & Eastern Europe, 2018 – 2028 (2 of 2)
Figure 13‑13: Cardiac Ablation Procedures by Country, Middle East, 2018 – 2028
Figure 13‑14: Cardiac Ablation Procedures by Country, Asia-Pacific, 2018 – 2028 (1 of 3)
Figure 13‑15: Cardiac Ablation Procedures by Country, Asia-Pacific, 2018 – 2028 (2 of 3)
Figure 13‑16: Cardiac Ablation Procedures by Country, Asia-Pacific, 2018 – 2028 (3 of 3)
Figure 13‑17: Cardiac Ablation Procedures by Country, Africa, 2018 – 2028
Figure 13‑18: RF Ablation Procedures by Region, Global, 2018 – 2028
Figure 13‑19: RF Ablation Procedures by Country, North America, 2018 – 2028
Figure 13‑20: RF Ablation Procedures by Country, Latin America, 2018 – 2028 (1 of 2)
Figure 13‑21: RF Ablation Procedures by Country, Latin America, 2018 – 2028 (2 of 2)
Figure 13‑22: RF Ablation Procedures by Country, Western Europe, 2018 – 2028
Figure 13‑23: RF Ablation Procedures by Country, Central & Eastern Europe, 2018 – 2028 (1 of 2)
Figure 13‑24: RF Ablation Procedures by Country, Central & Eastern Europe, 2018 – 2028 (2 of 2)
Figure 13‑25: RF Ablation Procedures by Country, Middle East, 2018 – 2028
Figure 13‑26: RF Ablation Procedures by Country, Asia-Pacific, 2018 – 2028 (1 of 3)
Figure 13‑27: RF Ablation Procedures by Country, Asia-Pacific, 2018 – 2028 (2 of 3)
Figure 13‑28: RF Ablation Procedures by Country, Asia-Pacific, 2018 – 2028 (3 of 3)
Figure 13‑29: RF Ablation Procedures by Country, Africa, 2018 – 2028
Figure 13‑30: Cryoablation Procedures by Region, Global, 2018 – 2028
Figure 13‑31: Cryoablation Procedures by Country, North America, 2018 – 2028
Figure 13‑32: Cryoablation Procedures by Country, Latin America, 2018 – 2028 (1 of 2)
Figure 13‑33: Cryoablation Procedures by Country, Latin America, 2018 – 2028 (2 of 2)
Figure 13‑34: Cryoablation Procedures by Country, Western Europe, 2018 – 2028
Figure 13‑35: Cryoablation Procedures by Country, Central & Eastern Europe, 2018 – 2028 (1 of 2)
Figure 13‑36: Cryoablation Procedures by Country, Central & Eastern Europe, 2018 – 2028 (2 of 2)
Figure 13‑37: Cryoablation Procedures by Country, Middle East, 2018 – 2028
Figure 13‑38: Cryoablation Procedures by Country, Asia-Pacific, 2018 – 2028 (1 of 3)
Figure 13‑39: Cryoablation Procedures by Country, Asia-Pacific, 2018 – 2028 (2 of 3)
Figure 13‑40: Cryoablation Procedures by Country, Asia-Pacific, 2018 – 2028 (3 of 3)
Figure 13‑41: Cryoablation Procedures by Country, Africa, 2018 – 2028
Figure 13‑42: Cardiac Ablation Catheter Market by Segment, Global, 2018 – 2028 (US$M)
Figure 13‑43: Cardiac Ablation Catheter Market by Region, Global, 2018 – 2028 (US$M)
Figure 13‑44: Cardiac Ablation Catheter Market, Global, 2018 – 2028
Figure 13‑45: Units Sold by Region, Cardiac Ablation Catheter Market, Global, 2018 – 2028
Figure 13‑46: Average Selling Price by Region, Cardiac Ablation Catheter Market, Global, 2018 – 2028 (US$)
Figure 13‑47: Market Value by Region, Cardiac Ablation Catheter Market, Global, 2018 – 2028 (US$M)
Figure 13‑48: RF Ablation Catheter Market, Global, 2018 – 2028
Figure 13‑49: Units Sold by Region, RF Ablation Catheter Market, Global, 2018 – 2028
Figure 13‑50: Average Selling Price by Region, RF Ablation Catheter Market, Global, 2018 – 2028 (US$)
Figure 13‑51: Market Value by Region, RF Ablation Catheter Market, Global, 2018 – 2028 (US$M)
Figure 13‑52: Cryoablation Catheter Market, Global, 2018 – 2028
Figure 13‑53: Units Sold by Region, Cryoablation Catheter Market, Global, 2018 – 2028
Figure 13‑54: Average Selling Price by Region, Cryoablation Catheter Market, Global, 2018 – 2028 (US$)
Figure 13‑55: Market Value by Region, Cryoablation Catheter Market, Global, 2018 – 2028 (US$M)
Figure 13‑56: Leading Competitors, Cardiac Ablation Catheter Market, Global, 2021
Figure 13‑57: Leading Competitors by Region, Cardiac Ablation Catheter Market, Global, 2021
Figure 13‑58: Leading Competitors by Region, RF Ablation Catheter Market, Global, 2021

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Explore Options

Report Summary

FREE

Select License Type

The full report suite on the global market for cardiac rhythm management, electrophysiology & cardiac ablation includes pacemakers, implantable cardioverter-defibrillators (ICDs), cardiac resynchronization therapy devices (CRTs), cardiac leads, implantable loop recorders (ILRs), electrophysiology (EP) lab systems, diagnostic electrophysiology (EP) catheters and cardiac ablation catheters.

  • 2022
  • 10 Years
  • Global
  • 11/24/2022
  • 755
  • MedSuite
0
    0
    Your Cart
    Your cart is emptyReturn to Report Library